OptiBiotix HealthSTU:OB3 +1.39% Days Payable is 197.26 as of Dec. 2025, which is 44% above its 10-year median of 136.98. The stock has 4 warning signs investors should review. Among 700 Biotechnology companies, OptiBiotix Health ranks better than 63.29% on this metric.
The historical rank and industry rank for OptiBiotix Health's Days Payable or its related term are showing as below:
STU:OB3'
s Days Payable Range Over the Past 10 Years
Min: 49.32 Med: 136.98 Max: 526.94
Current: 198.37
During the past 13 years, OptiBiotix Health's highest Days Payable was 526.94. The lowest was 49.32. And the median was 136.98.
STU:OB3's Days Payable is ranked better than 63.29% of 700
companies
in the Biotechnology industry
Industry Median: 113.1
vs STU:OB3: 198.37
OptiBiotix Health's Days Payable
increased
from Dec. 2024 (140.82) to Dec. 2025 (197.26).
It may suggest that OptiBiotix Healthdelayed paying its suppliers.
OptiBiotix Health Days Payable Related Terms
OptiBiotix Health Days Payable Historical Data
* Premium members only.
The historical data trend for OptiBiotix Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:OB3 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, OptiBiotix Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OptiBiotix Health Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Days Payable distribution charts can be found below:
* The bar in red indicates where OptiBiotix Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
OptiBiotix Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OptiBiotix Health (STU:OB3) has a Days Payable of 197.26 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OptiBiotix Health and its competitors. This is 44% above median its historical median of 136.98. Over the past decade, OptiBiotix Health's Days Payable has ranged from 49.32 to 526.94. According to the industry distribution chart, OptiBiotix Health ranks #257 out of 700 companies in the Biotechnology industry, placing it in the top 36.7%.
Is OptiBiotix Health's Days Payable too high?
OptiBiotix Health's current Days Payable of 197.26 is 44% above median its 10-year median of 136.98. Over the past 10 years, this metric has ranged from a low of 49.32 to a high of 526.94. The Biotechnology industry median Days Payable is 113.10. OptiBiotix Health's value of 197.26 is 74.4% above this industry median. Based on the distribution chart, OptiBiotix Health ranks #257 out of 700 companies in the Biotechnology industry, which is above the industry midpoint.
How does OptiBiotix Health's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OptiBiotix Health ranks #257 out of 700 companies for Days Payable. This puts OptiBiotix Health in the upper half of its industry. The industry median Days Payable is 113.10. OptiBiotix Health's value of 197.26 is 74.4% above this benchmark. Historically, OptiBiotix Health's own Days Payable has ranged from 49.32 to 526.94 over the past decade. While the company's 10-year median is 136.98 vs. the industry median of 113.10, OptiBiotix Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OptiBiotix Health's current Days Payable of 197.26 is 74.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on OptiBiotix Health and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OptiBiotix Health's current Days Payable is 197.26, which is 44% above median its own 10-year median of 136.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptiBiotix Health stock overvalued right now?
OptiBiotix Health (STU:OB3) has a current Days Payable of 197.26. The stock's GF Value™ is €0.34, compared to a current price of €0.07 — trading 78.5% below its estimated fair value. The current Days Payable is 197.26, which is 44% above median its 10-year median of 136.98 and 74.4% above the Biotechnology industry median of 113.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For OptiBiotix Health (STU:OB3), the current Days Payable is 197.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OB3 has been successfully added to your 